Trends in the Initial Management of Primary Angle-Closure Glaucoma: A 2010-2025 Study of Peripheral Iridotomy versus Phacoemulsification
Clinical Ophthalmology · 2026-11 · Volume 20 · 1-8
DOI: 10.2147/opth.s659332 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Ophthalmology, 2026-11. Verfasst von Daniel Zhu und 11 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Purpose
We sought to evaluate temporal trends in the use of laser peripheral iridotomy (LPI) vs phacoemulsification as the initial intervention for primary angle-closure glaucoma (PACG) in the United States.
Methods
We conducted a cross-sectional time-series study of 6535 adults (≥ 18 years) with a diagnosis of PACG who underwent an initial LPI or phacoemulsification with or without minimally invasive glaucoma surgery (MIGS) between January 1, 2010, and December 31, 2025. Patients with prior glaucoma surgery, LPI, or phacoemulsification were excluded. Patients were stratified into two age cohorts (< 50 years and ≥ 50 years), and the proportion undergoing each initial intervention was assessed in 4-year increments to create time quartiles. Trends were analyzed using Cochran–Armitage tests.
Results
In the < 50 cohort, initial phacoemulsification increased from 14.00% in 2010– 2013 to 26.42% in 2022– 2025, while LPI decreased from 86.00% to 73.58% (p=0.0042). In the ≥ 50 cohort, initial phacoemulsification increased from 14.26% to 48.39%, with a corresponding decline in LPI from 85.74% to 51.61% (p< 0.0001). The magnitude of increase in phacoemulsification was greater in the ≥ 50 cohort.
Conclusions
This study found that a growing proportion of PACG patients, both < 50 and ≥ 50 years old, are initially treated with phacoemulsification as opposed to LPI in the United States. The increase in initial phacoemulsification highlights its growing role in PACG management, likely driven by evolving clinical evidence that suggests early lens extraction may be a more effective initial management strategy for PACG patients.
Zitieren
APA
Zhu, D., Shah, P. P., Schulgit, M., Zhang, C., Elhusseiny, A. M., Lee, A., Lau, N., Labkovich, M., Bouaziz, M., Goldburg, S., Djougarian, A., & Qiu, M. (2026). Trends in the Initial Management of Primary Angle-Closure Glaucoma: A 2010-2025 Study of Peripheral Iridotomy versus Phacoemulsification. Clinical Ophthalmology, Volume 20, 1-8. https://doi.org/10.2147/opth.s659332
Vancouver
Zhu D, Shah PP, Schulgit M, Zhang C, Elhusseiny AM, Lee A, et al. Trends in the Initial Management of Primary Angle-Closure Glaucoma: A 2010-2025 Study of Peripheral Iridotomy versus Phacoemulsification. Clinical Ophthalmology. 2026;Volume 20:1-8. doi:10.2147/opth.s659332
BibTeX
@article{Zhu2026,
author = {Zhu, Daniel and Shah, Paras P and Schulgit, Matthew and Zhang, Charles and Elhusseiny, Abdelrahman M and Lee, April and Lau, Nathan and Labkovich, Margarita and Bouaziz, Michael and Goldburg, Samantha and Djougarian, Alina and Qiu, Mary},
title = {Trends in the Initial Management of Primary Angle-Closure Glaucoma: A 2010-2025 Study of Peripheral Iridotomy versus Phacoemulsification},
journal = {Clinical Ophthalmology},
year = {2026},
volume = {Volume 20},
pages = {1--8},
doi = {10.2147/opth.s659332}
}
EUVIMED